Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients

Infection ◽  
2018 ◽  
Vol 46 (3) ◽  
pp. 431-434 ◽  
Author(s):  
Morgan Hakki ◽  
James S. Lewis
2020 ◽  
Vol 7 (7) ◽  
Author(s):  
Flaminia Olearo ◽  
Ilona Kronig ◽  
Stavroula Masouridi-Levrat ◽  
Yves Chalandon ◽  
Nina Khanna ◽  
...  

Abstract In a large, multicenter, contemporary, 8-year, cohort study, one third of allogeneic-hematopoietic cell transplant (HCT) recipients with Pseudomonas aeruginosa (PSA) infection developed a recurrent infection within 3 months. Antibiotic treatment duration of ≥14 days was the only significantly associated variable with reduced recurrence rates of PSA infections in allogeneic-HCT recipients.


2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S266-S267 ◽  
Author(s):  
Christopher Kovacs ◽  
Vasilios Athans ◽  
David Lang ◽  
Ronald Sobecks ◽  
Lisa Rybicki ◽  
...  

2021 ◽  
Vol 27 (3) ◽  
pp. S124
Author(s):  
Issam S. Hamadeh ◽  
Michael R. Grunwald ◽  
Allison Martin ◽  
Jai N. Patel ◽  
Alexandra Wolff ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document